Autonomy Research Group is a consultancy firm based in Trondheim, Norway. With dedicated researchers who are experts in their fields, we specialize in helping companies realize projects in autonomous systems and mobile robotics. While Autonomy Research Group provides consulting services within autonomous systems technology to companies, we attend DNB NXT due to our in-house project, where we are looking to network and talk to investors with expertise in the automotive sector.

Infopix has developed a complete solution for distributing useful information through digital information screens. We use small web-based computers like ChromeBit and also have integration with other slideshow-based platforms. We provide live data from different providers like news, weather, and flights. stocks, currencies, culture, movies, tourist information, events, and more, with customizable playlists per screen

WAKT er et oppstartsselskap basert i Drammen. Våre kompetanseområder ligger innenfor: Robotic Process Automation Development,Data EngineeringMachine LearningQuantitative financial Engineering and Analysis.Application Development Vi streber etter å ta i bruk moderne teknologi for å levere resultatene vi eller våre kunder er ute etter.

NEOFRAME har designbeskyttet et dørkarm- og vinduskarmsystem som er ekstremt enkelt og rask å montere og som gir en perfekt resultat, profesjonell tømrer eller ikke. Karm, fóringer og lister kan leveres med NEOFRAME LIM eller NEOFRAME KLIKK som gjør at fóringer og lister lett klikkes på plass. Hjørnene kan leveres 90 eller 45 grader. Det blir ingen spikerhull i listene, du får perfekte hjørner – hver gang. Vi har også utviklet – valget er ditt. Vår teknologi involverer nye design på lister og nye produkter som vil revolusjonere listverksproduksjon og rask montering av listverk uten synlig spikring, spesielt ved produksjon av nye boliger.

Entro is an energy- and environmental consultancy firm with two clients – our customers and the environment. We save our customers time and money, and we help the environment by reducing energy consumption and carbon footprints. Entro has about 60 employees in Oslo, Trondheim, and Bergen. We had a turnover of NOK 63 million in 2016 and saved our customers NOK 400 million. Entro has a unique interdisciplinary expertise with a good mix of practical and academic skills. Among our staff we have more trade certificates in electrical and construction, more than 60% of the employees are civil engineers and engineers and we have several employees with training in economics and management. We have expertise in electrical, plumbing, building, environment, and IT.

CardiNor AS er et norsk bioteknologiselskap etablert for å håndtere kommersialiseringen av secretoneurin, en ny biomarkør test for hjertekar sykdom. Vår innovasjon er en ny og proprietær hjertekar test – secretoneurin. Secretoneurin er vist å ha sterk prognostisk nytteverdi hos pasienter med hjertesvikt, og den har et særskilt stort potensial hos pasienter med hjerterytmeforstyrrelser (arytmi). Hjertekar sykdom er fortsatt den viktigste dødsårsaken i verden i dag. Ingen av de kjent og etablerte biomarkørene for hjertekar sykdom er til særlig hjelp i valg av medisinske, og eller kirurgiske behandlingsmetoder for å forhindre livstruende hjerterytmeforstyrrelser. Selskapet utvikler nå en brukervennlig forskningstest for å måle secretoneurin blod som vil markedsført og solgt gjennom et nettverk av distributører i Europa og USA. Dette etterfulgt av introduksjonen av et CE-merket produkt for klinisk bruk i Europa og regulatorisk godkjenning i USA. CardiNor-ledelsen har inngående kunnskap om og erfaring fra bioteknologi og diagnostisk industri som dekker hele livssyklus fra oppstart til exit. CardiNor samarbeider med verdensledende akademiske institusjoner og opinionsledere og industri i å utvikle og dokumentere biomarkør testen.

"Lifeboats have killed more people than they have saved!" The statement is as far as I know unsupported, but widely known within the market of lifesaving equipment. Regulatory development, or rather a lack of such, has created a worldwide situation where lifesaving equipment on ships, ferries, cruise liners, you name it, have been torn between manufacturers, owners, service providers, and class and flag authorities, where all parties are biased by their commercial interest and their hopefully unconscious gamble that such equipment never has to be used. Not on their vessel. Not on my watch. The gamble is made with human lives at stake, and unfortunately, the odds are already written in blood. My system is based on my almost 20 years in this busyness. I have been a sailor who has trusted my own life on such equipment. I have been fortunate enough to use such equipment to save others. I have been responsible for the maintenance of such, I have worked with the leading manufacturers of such equipment as well as with companies providing service and inspections. I have also been part of the international organization responsible for the development of the rules for lifesaving equipment, and I have monitored this work closely for the last 10 years. I have seen all sides of the above-mentioned struggle. I know at the end of the day safety is at stake. I also have the solution. My system will benefit all parties and make equipment integrity and safety profitable for all. I am looking for a co-founder, CTO, and system developer to make my dream come true. I need someone with a passion to make a difference. Someone who values the thought of doing something nobody has done before, and who is willing to be in it for the long haul. I am sincerely looking forward to meeting you!

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Hei, mitt navn er Erik Johannesen og er gründer i det norske selskapet ID TAG TECHNOLOGY GROUP AS. Selskapet ID TAG TECHNOLOGY har en idé og teknologi som vi anser som støttende til innsamling av BIG DATA, og et utall andre muligheter innenfor dette konseptet. Vår ambisjon er at ID TAG TECHNOLOGY skal kan skape et nytt verdensomspennende markedsføringskonsept. ID TAG TECHNOLOGY sin patenterte teknologi/konsept har til hensikt å være en «plattform» for mange industrielle behov. Vi anser at vi kan lisensiere ut vår teknologi til logistikk, broadcast, marine, olje og gass mm. Utallige muligheter. Tenk deg at du tar et bilde med mobilkamera og kan se hvem som er på bildet med informasjon om vedkommende, samt at du kan se hvilken merkevare-/produsent som har produktene på bildet, i sanntid. Deretter trykker du på produktet på bildet som inneholder en url, og du blir sendt videre til produktets nettsted. Dette er ikke gjenkjennelses teknologi eller maskin learning, men rett informasjon som er skapt av de som ønsker å informere kundene i den store verden. ID TAG TECHNOLOGY ble etablert 2011, har en positiv PCT-rapport, og innleverte patentsøknader februar 2015 på en teknologi/konsept for å plassere/identifisere elektroniske tags/sensorer innenfor en billedramme i sanntid, både stillbilder og video/film i en rekke land. Både ideen og teknologien har oppfinnerhøyde. Teknologien som er beskrevet i patentsøknadene er utviklet/forsket på i samarbeid med SINTEF, og har pågått siden begynnelsen av 2011. Vi har nå utviklet en lab modell for å bevise at dette lar seg gjennomføre – dette kan du få se. ID TAG TECHNOLOGY GROUP har blitt innvilget patent i Norge, USA og Kina (2017). Det er for øvrig søkt patent i EPO, Russland, Hong Kong, Japan og Sør Korea. Søknadsprosessen går over all forventning. Teknologien kan benyttes både i profesjonelt utstyr og i personlige enheter som smarttelefoner og nettbrett/PC og egenutviklede hardwareprodukter for industrielle behov. Bruksområdene er mange, og vi har spesielt sett på kringkasting/film (produktplassering), markedsføring/varehandel, transport/distribusjon og sosiale medier. Vi ser store muligheter innenfor markedsføring og salg hvor interessenten har mer kontroll enn det som dagens trender tilsier.   Se gjerne våre illustrerende konsept filmer på vår hjemmeside: http://www.idtagtech.com  Med vennlig hilsen  Erik Johannesen Mob: +47 918 71 610 E-mail: erik.johannesen@bbnett.no Hjemmeside: http://www.idtagtech.com

Nordic Electrofuel offers a solution for the rapid transition from fossil to renewable electrical energy for all transport sectors. It is based on the conversion of renewable electric energy into liquid electro-fuels that can be as easily transported, stored, and used as conventional fossil hydrocarbons. It also provides a good solution to distribute and store stranded electrical energy. PTL (Power To Liquid) has been considered too expensive, but with the low electricity price in Norway and new efficient processing and upgrading solutions, it has become commercially feasible. Electrification of transportation is required to avoid catastrophic climate change. Battery- or cable-electric solutions are not feasible for transport like aviation and long-distance marine transport. Liquid energy carriers such as biofuels are desperately needed but limited. The fuel is free of sulfur and can therefore be used maritime industry as a fuel after 2022. The fuel emits much fewer particles and aromatics than conventional fossil fuel, so it also solves the local pollution problem. Competitive advantages: • Norway’s low electricity price from hydro and lately also wind power. • 20 - 30 % lower electricity consumption than with existing technology • Lower production price than advanced biofuels • Agreements in place for a site at Herøya, which has all utilities (cooling water, cheap renewable electricity, etc.) and processing expertise available. • About the same source to shaft efficiency as hydrogen, but with much lower total CAPEX due to no investment in distribution systems and engines.

iTarget er et komplett mediehus som kan betjene både store, mellomstore og små bedrifter. Vi har lang og god erfaring fra å jobbe med noen av Norge’s største merkevarer, internasjonale kunder og mindre lokale bedrifter. Hos oss finner du både innholdsproduksjon, markedsstrategi, videoproduksjon, markedsføringstjenester, markedsavdeling for hire, animasjonsfilm, webdesign og mye mer. Det vi er bygget på og som er en stor del av det vi tilbyr våre kunder er langsiktig verdibasert markedsføring. Per i dag er vi 5 ansatte og betjener kunder over hele landet fra våre kontorer i Bergen.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

In order to maintain Norway's position as the largest and most important ski nation in the world, climatic changes require new thinking, types of facilities, snow technologies, and strategies. HST has a letter of intent with Vestfold county to take over the Holmestrand 1862-meter car tunnel at NOK 1 to be redeveloped into a NOK 200 million all-year-around ski facility for cross country, biathlon, and Paralympics. With SIAT/NTNU and Terje, Grønmo Architects developed an opportunity study ("Mulighetsstudie" found at www.holmestrandskitunnel.no). Business and marketing plan currently at work with University College of Southeast Norway, Campus Kongsberg. Why Holmstrand? Because the town is entering into a stage of comprehensive transformation and development, merging three municipalities into a 24,000 people unit, with a number of developments and construction projects coming up downtown at the seaside during the next 5-20 years and a NOK 6,7 billion state investment in a new railway system that takes passengers to Oslo in 45 minutes. 1 million people can reach Holmestrand in one hour by railway and E18. The railway stop is 100 meters from the future ski facility, which might serve as a magnet for other developments, creating health and social conditions for people at large. With an undeveloped fjord area, there is an opportunity to create a sports hub for unique marine and ski activities. Other projects are Gjelsten's leisure island Langøya, Kullboden (1 acre), Uni Quarter (1 acre) Hakan (might have swimming and hotel facilities, an architect study to be opened this fall), new car-free and covered main street (Langgaten), high stories car and boat parking with the business opportunity, heating/cooling systems (fjernvarme) based on excess energy from ski tunnel and Hydro smelter cooling water being served by an NTNU master study, an extension of 1200 leisure boat facilities and undeveloped south town area under the name Hagemann Brygge. Hagemann, in particular, is an excellent 55,000 sq.m. seafront residential and business opportunity with an option to be developed together with the neighboring ski tunnel. The ski tunnel and Hagemann together with some of the other projects would certainly become a long-term investment opportunity.

Our vision is to design and operate a “Green High-Security Hyperscale Datacenter” with the lowest PUE (Power Usage Efficiency) in the world.Think BigStart SmallMove Fast. Development of Green High-Security Datacenters, embarking upon groundbreaking environmental and state-of-the-art power usage efficiency technology.

Game-changing technology for structural integrity monitoring. The Ferrx FEMM (Ferrx ElectroMagnetic Method) has been developed and tested for 2 decades, first by SINTEF and since 2005 by Ferrx. The method has provided unique features for the condition monitoring of steel structures. Material deterioration can be directly measured and early warning of risk for fatigue can be established long before any crack is detectable. Furthermore, the same sensors can also measure changes in metal loss, and thus provide for non-intrusive monitoring of internal corrosion and erosion in pipes. During the last years, instrumentation technology has been industrialized and the first commercial systems have been delivered and installed. Different types of instrumentation systems are available both for onshore and offshore/subsea applications. The industrialization, marinization, and production of the instrumentation systems are being done in cooperation with the most specialized suppliers. Ferrx is an independent company located in Trondheim, Norway with the business idea to provide the FEMM technology for different onshore and offshore markets to monitor the actual condition of steel structures and thus prevent loss of assets and pollution of the environment. The FEMM is protected by 2 patents and all rights are vested in Ferrx. The system for riser inspection has been qualified by DNV-GL in accordance with DNV-RP-A203 Technology Qualification.